NFKB1 and familial dilated cardiomyopathy: The LCZ696 and valsartan treatment of DCM rats markedly inhibited the levels of NF-κB mRNA in cardiac tissue (p < 0.001 and p < 0.05, respectively) compared to the untreated DCM animals.